ASHLEY KEHINDE: Open Payments
NPI 1225796683 · CALIFORNIA CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 2 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $247 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $119 |
Products named: REXULTI, Ozempic.
Industry payments across CA — which companies pay providers there.
